You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

moderate cGVHD

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in Worldwide (Ibrutinib)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Duarte, California
  • +47 more
Jul 15, 2022

GVHD Trial in Worldwide (INC424)

Active, not recruiting
  • Graft vs Host Disease
  • Sao Paulo, Brazil
  • +20 more
Oct 26, 2022

Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)

Active, not recruiting
  • Chronic Graft-versus-host Disease
  • Tucson, Arizona
  • +132 more
Oct 17, 2022

Hematological Malignancies Trial in Durham (fostamatinib)

Active, not recruiting
  • Hematological Malignancies
  • Durham, North Carolina
    Duke University of Medicine
Jul 14, 2022

Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

Active, not recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 29, 2022

Graft Vs Host Disease Trial in Shenzhen (Umbilical Cord Mesenchymal Stem Cell Therapy)

Recruiting
  • Graft Vs Host Disease
  • Umbilical Cord Mesenchymal Stem Cell Therapy
  • Shenzhen, Guangdong, China
    Li Yu
Dec 4, 2021

Chronic GVHD Trial in Worldwide (ibrutinib, Placebo, Prednisone)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Scottsdale, Arizona
  • +101 more
Jan 24, 2022

Chronic Graft-versus-host-disease Trial in Monterrey (Low-dose ibrutinib)

Recruiting
  • Chronic Graft-versus-host-disease
  • Low-dose ibrutinib
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Apr 21, 2022

Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute

Recruiting
  • Chronic Graft vs Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Dry Eye Trial in Guangzhou (Umbilical Mesenchymal Stem Cells derived Exosomes)

Recruiting
  • Dry Eye
  • Umbilical Mesenchymal Stem Cells derived Exosomes
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Feb 10, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Baltimore, Maryland
  • +3 more
Aug 8, 2022

Chronic GVHD Trial in Worldwide (ECP Methoxsalen, Standard of Care)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • ECP Methoxsalen
  • Standard of Care
  • Miami, Florida
  • +31 more
Feb 7, 2020

Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

Recruiting
  • Chronic Graft Versus Host Disease
  • Duarte, California
    City of Hope Site Number : 8400001
Nov 23, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

Recruiting
  • Chronic GVHD
  • Bethesda, Maryland
  • +1 more
Jan 26, 2023

Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))

Recruiting
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cells (MSCs)
  • Shapingba, Chongqing, China
    Xinqiao Hospital
Nov 24, 2023

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

    Recruiting
    • Chronic Graft vs Host Disease
      • Bucheon-Si, Korea, Republic of
      • +9 more
      Jan 27, 2023

      Clinical and Biological Factors Determining Outcomes in Chronic

      Recruiting
      • Chronic Graft vs Host Disease
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

        Not yet recruiting
        • Chronic Graft Versus Host Disease
        • +2 more
        • Biopsy
        • +11 more
        • Duarte, California
          City of Hope Medical Center
        Aug 7, 2023

        Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

        Recruiting
        • Chronic Graft-versus-Host-Disease
        • +4 more
          • San Francisco, California
          • +15 more
          Jun 17, 2022

          Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

          Not yet recruiting
          • Chronic Graft Versus Host Disease
          • Atlanta, Georgia
            Northside Hospital
          Sep 21, 2023